Quick Answer
SOPHiA GENETICS SA reported R&D Expense of $34.22 million for fiscal year 2025.
SOPHiA GENETICS SA R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $34.22M | -0.4% |
| 2024 | $34.37M | -7.0% |
| 2023 | $36.97M | +4.5% |
| 2022 | $35.37M | +33.1% |
| 2021 | $26.58M | +43.0% |
| 2020 | $18.59M | +23.8% |
| 2019 | $15.02M | — |
- SOPHiA GENETICS SA showed a decrease of -0.4% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, SOPHiA GENETICS SA’s r&d expense has grown by 127.8% (from $15.02 million to $34.22 million).
- The most recent figure is from SOPHiA GENETICS SA’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: